Home | Hastings Center Report | The Hastings Center | Contact Us | Sign up for Bioethics Forum news and updates | RSS RSS

Bioethics Forum - Diverse Commentary on Issues in Bioethics

Home Articles By Author Articles By Date Articles By Subject
Science and Society

Friday, April 18, 2008
A Stem Cell Compromise?
BY BONNIE STEINBOCK

In a Forum essay on April 4, commentator Jesse Reynolds heralded the use of induced pluripotent stem cells (iPS cells) as an advance that could end the stem cell wars, but warns against the extremists on both sides who are more interested in seeing the battle continue than in reaching a sensible solution. He writes, “Advocates of stem cell research are downplaying iPS cells as ‘hype’ after years of routinely exaggerating the potential of embryonic stem cells. Responding to commentators who voice hopes that the stem cell wars could be drawing to a close, these enthusiasts have focused on the shortcomings and early stage of research with iPS cells while ignoring the many remaining uncertainties of embryonic stem cells.”

It surely is hype to maintain that we already have an alternative to human embryonic stem cells for purposes of research and possible therapy. No one yet knows if iPS cells will prove as malleable as embryonic stem cells have already proved to be, while there are serious safety considerations that will need to be resolved before iPS cells could be tried in human beings. All of this Reynolds grants. Why, then, does he tar those who make this claim as “extremists”?

Reynolds then goes on to cite approvingly Kass’s call for a moratorium on hESC research for four or five years to give iPS research a chance to mature and, hopefully, make research on human embryos unnecessary. He writes, “But if iPS does not fulfill its potential, then Kass is implying that he would find cloning for research acceptable, as long reproductive cloning is prohibited.”

If this were actually what Kass said, it might seem to be a viable compromise. Those supporting embryonic stem cell research give up four to five years of potential promise in return for a willingness on the part of opponents to accept cloned embryos for research purposes if iPS research doesn’t fulfill its promise. But what Kass actually said was very different:

Politically as well, this triple-pronged approach is a winner for all sides. Because the latest science has made creating embryos for research unnecessary and inefficient by comparison with reprogramming, we have the chance to put stem cell science on a footing that all citizens can endorse. Indeed, in return for accepting a moratorium on a scientific approach that is not very useful (creation of new embryos for research), scientists could exact large sums in public support for an exciting area of science. With pro-lifers as their biggest allies, they could obtain the research dollars they need – and their supposed enemies would write the biggest checks. Meanwhile, at the very time the latest science has made affronts to human procreation – cloning, but not only cloning – more likely and even imminent, pro-lifers and scientists can come together to ban these practices in America, as they have already been banned in the rest of the civilized world, without implicating the research debate at all.

Clearly, Kass thinks that “the latest science” already shows that it is unnecessary to create embryos for research. This being the case, it’s not clear why he calls for a moratorium, as opposed to an outright ban, at all – unless it’s to give the appearance of a compromise where none exists. Research on both hES and iPS cells should continue until we learn which (if either) is useful in the treatment of disease. That’s not extremist. It’s what’s called for by the science.

Comment on this essay.

Comments are sent to the forum moderator. Select responses may be posted.

Readers Respond to "A Stem Cell Compromise?”"

Although I am glad to see that my recent column in Bioethics Forum led to a response, I was disheartened that it misrepresented my position. While I asserted that we should consider a moratorium on cloning-based stem cell research, Bonnie Steinbock recasts this as a call for a moratorium on all human embryonic stem cell research.

She writes that I “cite approvingly Kass’s call for a moratorium on hESC research for four or five years.” Yet the part of Kass's proposal which I cited was a call for a moratorium on the creation of embryos – by any means – specifically for research purposes. Considering that the previous paragraphs in my column discussed the lack of progress on, and additional challenges posed by, cloning-based stem cell research, I believe it was clear that my argument applied to cloning-based work.

In addition, the closing of Ms. Steinbock's column again implies that I called for all human embryonic stem cell research to end. Noting that I warn against extremists on both sides of the stem cell debates, she argues that “Research on both hES and iPS cells should continue until we learn which (if either) is useful in the treatment of disease. That’s not extremist. It’s what’s called for by the science.” In fact, I explicitly endorsed this very approach: “This is certainly not the time to end embryonic stem cell research.”

The “extremists” I had in mind – and unfortunately they are common on both sides of the unproductive political war over stem cell research – are those who attribute hyperbole and political opportunism only to the other side.

– Jesse Reynolds

On The Web

A Phony 'War on Science'
Michael Gerson, Washington Post
“In their talk of a Republican war on science, liberals may be blinding themselves to a very different kind of modern war in which their own ideals are deeply implicated: a war on equality.”

It’s Not Immoral to Want to be Immortal
Arthur Caplan, MSNBC
“Despite a lot of hand-wringing and finger-pointing, it is not obvious that wanting to live a lot longer is evil or immoral.”

Science Is Leading Us to More Answers, but It's Also Misleading Us
David A. Shaywitz, Washington Post
“Consumers of scientific information must balance the hope we place in global biology with the skepticism this field has surely earned.”

Taking the Scary out of Breast Cancer Stats
Carol Tavris and Avrum Bluming, LA Times
“The media understand how deeply women fear breast cancer, and the result is that every study that seems to find a link between some new risk factor and the disease makes headlines everywhere.”

Dollars to Doughnuts Diagnosis
Albert Fuchs, LA Times
“Insurance doesn't make routine care affordable; it makes it more expensive by adding a middleman.”

Tainted Medicine
Jerome P. Kassirer, LA Times
“Disclosure of financial ties may give a scientist or researcher a clean conscience, but that doesn't erase the possibility of a conflict.”

Children's health can't be left to faith alone
Arthur Caplan, MSNBC
“Parents do not have the right to watch a child wither away while they pray.”

Transplant List Numbers Raise Doubts
Arthur Caplan, MSNBC
“The American people have a right to expect absolute honesty about the number of people waiting for a transplant at any time.”

An Epidemic No One Wants to Talk About
Robert E. Fullilove et al., Washington Post
“Simply put, we will never rid the United States of HIV and other STDs if our only weapon is medical treatment.”

Making Cells Like Computers
Erik Parens, Boston Globe
“Conceivably, we are on the verge of installing synthetic genomes in bacterial cells to create products we want. But we are still a long, long way from doing what most people mean by ‘synthesizing life.’”

Miracle Workers?
David Rieff, New York Times Magazine
“Even today, the oldest of all relations between patient and physician — that of supplicant to shaman — continues to exert its authority.”

Overselling Overmedication
Judith Warner, NYTimes.com
“Most of the critics decrying the over-medicalization of the American mind rest their arguments upon the bedrock assumption that people who have nothing wrong with them are being medicated for largely fictitious concerns.”

Ads Spur Urge for Drugs
David Lazarus, LA Times
“DTC advertising has turned prescription drugs into just another gotta-have-it consumer product.”

Food Politics, Half-Baked
James E. McWilliams, New York Times
“Lost in this rhetorical battle was a quiet middle ground where the benefits and drawbacks of genetically engineered crops were responsibly considered.”

Perpetrating the Autism Myth
Benjamin Kruskal and Carole Allen, Boston Globe
“The scientific evidence is clear: neither the MMR vaccine nor thimerosal (mercury) in vaccines has any relationship to autism.”

Closing the Barn Door After the Cows Have Gotten Out
Verlyn Klinkenborg, New York Times
“The real beneficiaries are the nation’s large meatpacking companies — the kind that would like it best if chickens grew in the shape of nuggets.”

Human Embryos Cloned: What Does It Mean?
Art Caplan, MSNBC
“Let's not be frightened by scare tactics into not funding research that may be the key to curing what is currently incurable.”

Don’t Ask, Don’t Tell Is Bad Policy for Cloned Food
Art Caplan, MSNBC
“All of this fear-mongering about clones has made Americans forget that cloning is nothing more than artificially creating twins.”

Contact Us | Privacy | Terms Of Use 

© The Hastings Center 2008